NCT05571579

Brief Summary

The objective of this study is to build a collection of biological samples from patients with brain tumors.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
92mo left

Started Nov 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress25%
Nov 2023Nov 2033

First Submitted

Initial submission to the registry

October 3, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 7, 2022

Completed
1.1 years until next milestone

Study Start

First participant enrolled

November 22, 2023

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 22, 2033

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 22, 2033

Last Updated

January 20, 2026

Status Verified

January 1, 2026

Enrollment Period

10 years

First QC Date

October 3, 2022

Last Update Submit

January 16, 2026

Conditions

Brain Tumor

Keywords

Brain tumor

Outcome Measures

Primary Outcomes (1)

  • number of biological samples

    number of biological samples

    10 years

Study Arms (1)

brain tumors

Biological: blood and/or csf collection

Interventions

blood and/or csf collectionBIOLOGICAL

blood and/or collection Only once : * 1 tube of blood of 4 mL on dry tube with or without gel, * 2 tubes of blood of 4 mL on EDTA tube, If CSF collected for diagnosis is available, it can be sent for storage in the collection.

brain tumors

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient with brain tumor

You may qualify if:

  • Patient whose diagnosis of brain tumor has been confirmed.
  • Adult patients, from 18 years old and without upper age limit
  • Patient affiliated to a social security scheme or equivalent.
  • Patient able to consent, having dated and signed an informed consent

You may not qualify if:

  • Pregnant or breastfeeding women
  • Patient under guardianship or curators.
  • Persons deprived of their liberty by a judicial or administrative decision

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospices Civils de Lyon

Bron, Rhône, 69500, France

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

* 1 tube of blood of 4 mL on dry tube with or without gel, * 2 tubes of blood of 4 mL on EDTA tube, If CSF collected for diagnosis is available, it can be sent for storage in the collection.

MeSH Terms

Conditions

Brain Neoplasms

Condition Hierarchy (Ancestors)

Central Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Central Study Contacts

François DUCRAY, Pr

CONTACT

04 72 68 13 21francois.ducray@chu-lyon.fr

Apolline Barthelmé

CONTACT

04 26 73 97 87Apolline.barthelme@chu-lyon.fr

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 3, 2022

First Posted

October 7, 2022

Study Start

November 22, 2023

Primary Completion (Estimated)

November 22, 2033

Study Completion (Estimated)

November 22, 2033

Last Updated

January 20, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)